040300055	040300055	CD	B-NP	O
|	|	NN	I-NP	O
MH	MH	NN	I-NP	O
|	|	NN	I-NP	O
20138857	20138857	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6399076	6399076	CD	B-NP	O
|	|	CC	I-NP	O
3/19/2004	3/19/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/19/2004	3/19/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
DAMIAN	DAMIAN	NNP	B-NP	O
GRUHN	GRUHN	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
Date	Date	NNP	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
determined	determine	VBN	I-VP	O
.	.	.	O	O

SERVICE	SERVICE	NN	B-NP	O
:	:	:	O	O
General	General	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
Bile	Bile	NNP	I-NP	O
Port	Port	NNP	I-NP	O
In	In	IN	B-PP	O
summary	summary	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
73-year-old	73-year-old	JJ	I-NP	O
lady	lady	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
sciatica	sciatica	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
hypothyroidism	hypothyroidism	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
posthepatic	posthepatic	JJ	B-NP	O
neuralgia	neuralgia	NN	I-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
deep	deep	JJ	B-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
total	total	JJ	I-NP	O
knee	knee	NN	I-NP	O
replacement	replacement	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
8/15/04	8/15/04	CD	B-NP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
following	follow	VBG	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
continuation	continuation	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
events	event	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
stated	state	VBN	B-VP	O
before	before	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
suffers	suffer	VBZ	B-VP	O
from	from	IN	B-PP	O
debilitating	debilitate	VBG	B-VP	O
low	low	JJ	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
from	from	IN	B-PP	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
steroid/analgesic	steroid/analgesic	JJ	I-NP	O
epidural	epidural	JJ	I-NP	O
injection	injection	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Service	Service	NNP	I-NP	O
followed	follow	VBD	B-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
fentanyl	fentanyl	NN	I-NP	O
patch	patch	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
p.o.	p.o.	FW	I-NP	O
Dilaudid	Dilaudid	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
including	include	VBG	B-PP	O
Neurontin	Neurontin	NN	B-NP	B-protein
and	and	CC	I-NP	O
Elavil	Elavil	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
sedation	sedation	NN	B-NP	O
with	with	IN	B-PP	O
too	too	RB	B-NP	O
much	much	JJ	I-NP	O
narcotics	narcotic	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
narcotics	narcotic	NNS	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
for	for	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
IV	IV	CD	B-NP	O
conscious	conscious	JJ	I-NP	O
sedation	sedation	NN	I-NP	O
MRI	MRI	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
normal	normal	JJ	I-NP	O
spinal	spinal	JJ	I-NP	O
cord	cord	NN	I-NP	O
and	and	CC	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
facet	facet	NN	B-NP	O
involvement	involvement	NN	I-NP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
early	early	RB	B-ADVP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
indication	indication	NN	I-NP	O
for	for	IN	B-PP	O
orthopedic	orthopedic	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
reconsulted	reconsulte	VBN	I-VP	O
later	later	RB	B-ADVP	O
on	on	IN	B-PP	O
when	when	WRB	B-ADVP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
want	want	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
surgery	surgery	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
orthopedics	orthopedic	NNS	I-NP	O
surgery	surgery	NN	I-NP	O
determined	determine	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
risk-benefit	risk-benefit	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
favor	favor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
a	a	DT	B-NP	O
surgical	surgical	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
context	context	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
newly	newly	RB	I-NP	O
developed	develop	VBN	I-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
DVT	DVT	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
before	before	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
epidural	epidural	JJ	I-NP	O
injection	injection	NN	I-NP	O
with	with	IN	B-PP	O
bupivacaine	bupivacaine	NN	B-NP	O
and	and	CC	I-NP	O
steroids	steroid	NNS	I-NP	O
on	on	IN	B-PP	O
7/8/05	7/8/05	CD	B-NP	O
with	with	IN	B-PP	O
minimal	minimal	JJ	B-NP	O
initial	initial	JJ	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
later	later	RB	B-ADVP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
some	some	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Pain	Pain	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
further	further	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
follow	follow	NN	I-NP	O
up	up	RP	B-PRT	O
section	section	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
repeat	repeat	NN	I-NP	O
epidural	epidural	JJ	I-NP	O
injection	injection	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Farella	Farella	NNP	I-NP	O
within	within	IN	B-PP	O
four	four	CD	B-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Orthopedics	Orthopedics	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
reevaluation	reevaluation	NN	B-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
orthopedics	orthopedic	NNS	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
aggressive	aggressive	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
slowly	slowly	RB	B-ADVP	O
enabled	enable	VBD	B-VP	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
movement	movement	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
have	have	VB	I-VP	O
chronic	chronic	JJ	B-NP	O
and	and	CC	I-NP	O
stable	stable	JJ	I-NP	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
immobility	immobility	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
somewhat	somewhat	RB	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
slowly	slowly	RB	B-ADVP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
very	very	RB	B-ADJP	O
agreeable	agreeable	JJ	I-ADJP	O
of	of	IN	B-PP	O
recent	recent	JJ	B-NP	O
days	day	NNS	I-NP	O
to	to	TO	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
expected	expect	VBN	I-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
with	with	IN	B-PP	O
continued	continue	VBN	B-NP	O
aggressive	aggressive	JJ	I-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
mainstay	mainstay	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
treatment	treatment	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
premedicated	premedicate	VBN	I-VP	O
with	with	IN	B-PP	O
Dilaudid	Dilaudid	NN	B-NP	O
or	or	CC	O	O
any	any	DT	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
medications	medication	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
any	any	DT	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
session	session	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
stable	stable	JJ	B-NP	O
cardiovascular	cardiovascular	JJ	I-NP	O
parameters	parameter	NNS	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
any	any	DT	B-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Medications	Medication	NNS	B-NP	O
are	be	VBP	B-VP	O
as	as	IN	B-SBAR	O
listed	list	VBN	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
discharge	discharge	NN	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
severe	severe	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
insulin	insulin	NN	B-NP	O
resistence	resistence	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
hypoglycemia	hypoglycemia	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
range	range	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
fasting	fast	VBG	I-NP	O
morning	morning	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
of	of	IN	B-PP	O
normal	normal	JJ	B-NP	O
need	need	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Synthroid	Synthroid	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
renal	renal	JJ	B-NP	O
insufficiency	insufficiency	NN	I-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
chronic	chronic	JJ	I-NP	O
low	low	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
issues	issue	NNS	I-NP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Rheumatology	Rheumatology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
rheumatoid	rheumatoid	JJ	B-NP	O
arthritis	arthritis	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
in	in	IN	B-PP	O
duration	duration	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
from	from	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
methotrexate	methotrexate	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
methotrexate	methotrexate	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
rheumatology	rheumatology	NN	I-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
as	as	RB	B-ADVP	O
soon	soon	RB	I-ADVP	O
as	as	IN	B-PP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
takes	take	VBZ	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Renal	Renal	JJ	B-ADVP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
on	on	IN	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
with	with	IN	B-PP	O
gentle	gentle	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
on	on	IN	B-PP	O
4/22/04	4/22/04	CD	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
and	and	CC	O	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
to	to	TO	I-NP	O
101	101	CD	I-NP	O
degrees	degree	NNS	I-NP	O
Fahrenheit	Fahrenheit	NN	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
white	white	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
empirically	empirically	RB	I-VP	O
given	give	VBN	I-VP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
MRSA	MRSA	NN	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
colonized	colonize	VBN	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
precautions	precaution	NNS	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
clinical	clinical	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
appeared	appear	VBD	B-VP	O
red	red	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
woody	woody	JJ	I-ADJP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
p.o.	p.o.	FW	B-NP	O
Keflex	Keflex	NNP	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unlikely	unlikely	JJ	B-ADJP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
She	She	NNP	B-NP	O
likely	likely	RB	B-ADJP	O
has	have	VBZ	B-VP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
O2	O2	NN	B-NP	O
saturations	saturation	NNS	I-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
clinically	clinically	RB	B-ADJP	O
significant	significant	JJ	I-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
and	and	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
x-rays	x-ray	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
taken	take	VBN	I-VP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
being	be	VBG	B-VP	O
fitted	fit	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
C-PAP	C-PAP	NN	I-NP	B-protein
mask	mask	NN	I-NP	I-protein
,	,	,	O	O
she	she	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
to	to	TO	I-VP	O
use	use	VB	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Hematology	Hematology	NNP	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diagnosed	diagnose	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
DVT	DVT	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
leg	leg	NN	I-NP	O
by	by	IN	B-PP	O
ultrasound	ultrasound	NN	B-NP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
bridged	bridge	VBN	I-VP	O
to	to	TO	B-PP	O
warfarin	warfarin	NN	B-NP	O
with	with	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
of	of	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
then	then	RB	O	O
reevaluation	reevaluation	NN	B-NP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
current	current	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
is	be	VBZ	B-VP	O
6	6	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
ensure	ensure	VB	I-VP	O
a	a	DT	B-NP	O
goal	goal	NN	I-NP	O
INR	INR	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
.	.	.	O	O

Until	Until	IN	B-PP	O
than	than	IN	B-SBAR	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
subu	subu	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-ADVP	O
per	per	IN	B-ADVP	O
above	above	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
engaged	engage	VBN	I-VP	O
in	in	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
improvement	improvement	NN	B-NP	O
over	over	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
intermittent	intermittent	JJ	B-NP	O
constipation	constipation	NN	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
poor	poor	JJ	B-NP	O
p.o.	p.o.	FW	I-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-PP	O
general	general	JJ	B-ADJP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
improved	improve	VBD	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
requires	require	VBZ	B-VP	O
an	an	DT	B-NP	O
aggressive	aggressive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
often	often	RB	B-ADVP	O
resonant	resonant	JJ	B-ADJP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movement	movement	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
feeling	feeling	NN	I-NP	O
of	of	IN	B-PP	O
vertigo	vertigo	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
improved	improve	VBN	B-VP	O
during	during	IN	B-PP	O
time	time	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	B-VP	O
allow	allow	VB	I-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
bowel	bowel	NN	B-NP	O
movement	movement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
goal	goal	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
sit	sit	VB	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
toilet	toilet	NN	I-NP	O
potty	potty	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
bedside	bedside	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Fluids	Fluid	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
nutrition	nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
,	,	,	I-NP	O
non-clinically	non-clinically	JJ	I-NP	O
significant	significant	JJ	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
initially	initially	RB	B-ADVP	O
was	be	VBD	B-VP	O
corrected	correct	VBN	I-VP	O
with	with	IN	B-PP	O
Kayexalate	Kayexalate	NN	B-NP	O
and	and	CC	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Psychiatric	Psychiatric	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
intermittent	intermittent	JJ	B-NP	O
vocalization	vocalization	NN	I-NP	O
of	of	IN	B-PP	O
not	not	RB	O	O
caring	care	VBG	B-VP	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
lived	live	VBD	B-VP	O
or	or	CC	I-VP	O
died	die	VBD	I-VP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
lived	live	VBN	I-VP	O
her	her	PRP$	B-NP	O
life	life	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
psychiatry	psychiatry	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
times	time	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
suicidal	suicidal	JJ	B-ADJP	O
and	and	CC	O	O
only	only	RB	B-VP	O
need	need	VBP	I-VP	O
emotional	emotional	JJ	B-NP	O
support	support	NN	I-NP	O
to	to	TO	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
euthymic	euthymic	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
hopeful	hopeful	JJ	I-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
eager	eager	JJ	B-ADJP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
quality	quality	NN	I-NP	O
of	of	IN	B-PP	O
life	life	NN	B-NP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
looking	look	VBG	I-VP	O
forward	forward	RB	B-ADVP	O
to	to	TO	B-PP	O
continuing	continue	VBG	B-VP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
management	management	NN	I-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
visit	visit	NN	B-NP	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
declared	declare	VBN	I-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
DNR/DNI	DNR/DNI	NNP	B-NP	O
.	.	.	O	O

TO-DO	TO-DO	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
,	,	,	O	O
FOLLOW-UP	FOLLOW-UP	NN	B-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aggressive	Aggressive	JJ	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
clinic	clinic	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

After	After	IN	B-PP	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
from	from	IN	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
rheumatologist	rheumatologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Boughamer	Boughamer	NNP	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cills	Cills	NNP	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
in	in	IN	B-PP	O
Orthopedics	Orthopedics	NNP	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
MRSA	MRSA	NN	B-NP	O
colonized	colonize	VBN	B-VP	O
and	and	CC	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
appropriate	appropriate	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
her	her	PRP$	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
months	month	NNS	I-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
deep	deep	JJ	I-NP	O
vein	vein	NN	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
until	until	IN	B-SBAR	O
otherwise	otherwise	RB	B-VP	O
directed	direct	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
physician	physician	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
clinic	clinic	NN	I-NP	O
will	will	MD	B-VP	O
consider	consider	VB	I-VP	O
additional	additional	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
including	include	VBG	B-PP	O
epidural	epidural	JJ	B-NP	B-DNA
repeat	repeat	NN	I-NP	I-DNA
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
restart	restart	VB	I-VP	O
her	her	PRP$	B-NP	O
methotrexate	methotrexate	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Boore	Boore	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Nardon	Nardon	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
at	at	IN	B-PP	O
Mont	Mont	NNP	B-NP	O
Ox	Ox	NNP	I-NP	O
Delp	Delp	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
286-351-0157	286-351-0157	CD	I-NP	O
on	on	IN	B-PP	O
7/9/05	7/9/05	CD	B-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
p.m.	p.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Christofferse	Christofferse	NNP	I-NP	O
,	,	,	O	O
Orthopedic	Orthopedic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Middrise	Middrise	NNP	I-NP	O
Et	Et	NNP	I-NP	O
Brynta	Brynta	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Orthopedic	Orthopedic	NNP	I-NP	O
Service	Service	NNP	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Jo	Jo	NNP	I-NP	O
Renford	Renford	NNP	I-NP	O
Pu	Pu	NNP	I-NP	O
Glenda	Glenda	NNP	I-NP	O
Li	Li	NNP	I-NP	O
Sabuffta	Sabuffta	NNP	I-NP	O
at	at	IN	B-PP	O
Park	Park	NNP	B-NP	O
Health	Health	NNP	I-NP	O
,	,	,	O	O
phone	phone	NN	B-NP	O
number	number	NN	I-NP	O
967-787-5406	967-787-5406	CD	I-NP	O
on	on	IN	B-PP	O
10/1/05	10/1/05	CD	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	RB	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
drawn	draw	VBN	B-VP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
until	until	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
rehabilitation/nursing	rehabilitation/nurse	VBG	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
1.25	1.25	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulizer	nebulizer	NN	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
Elavil	Elavil	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
bisacodyl	bisacodyl	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
folic	folic	JJ	B-NP	O
acid	acid	NN	I-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
3h	3h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
30	30	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
human	human	JJ	I-NP	O
54	54	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Synthroid	Synthroid	JJ	B-NP	O
125	125	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
milk	milk	NN	B-NP	O
of	of	IN	B-PP	O
magnesia	magnesia	NN	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
Sudafed	Sudafe	VBD	B-VP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
nasal	nasal	JJ	B-NP	O
congestion	congestion	NN	I-NP	O
,	,	,	O	O
senna	senna	NN	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
high	high	JJ	I-NP	O
vitamin	vitamin	NN	I-NP	O
K	K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
sustained	sustained	JJ	I-NP	O
release	release	NN	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
fentanyl	fentanyl	NN	B-NP	O
patch	patch	NN	I-NP	O
75	75	CD	I-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
transdermally	transdermally	RB	B-NP	O
q.	q.	NN	I-NP	O
72h	72h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Neurontin	Neurontin	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Dulcolox	Dulcolox	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PR	PR	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
15	15	CD	I-NP	O
mL	mL	NN	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
mL	mL	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.i.d.	q.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
titrate	titrate	NN	B-NP	O
to	to	TO	B-PP	O
one	one	CD	B-NP	O
to	to	TO	I-NP	O
two	two	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
7-2126464	7-2126464	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
MINGLE	MINGLE	NNP	B-NP	O
,	,	,	O	O
DON	DON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
HANLE	HANLE	NNP	B-NP	O
,	,	,	O	O
ALVARO	ALVARO	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0197216	0197216	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/15/05	9/15/05	CD	B-NP	O

